Abstract
Explainable artificial intelligence provides an opportunity to improve prediction accuracy over standard linear models using “black box” machine learning (ML) models while still revealing insights into a complex outcome such as all-cause mortality. We propose the IMPACT (Interpretable Machine learning Prediction of All-Cause morTality) framework that implements and explains complex, non-linear ML models in epidemiological research, by combining a tree ensemble mortality prediction model and an explainability method. We use 133 variables from NHANES 1999–2014 datasets (number of samples: n = 47, 261) to predict all-cause mortality. To explain our model, we extract local (i.e., per-sample) explanations to verify well-studied mortality risk factors, and make new discoveries. We present major factors for predicting x-year mortality (x = 1, 3, 5) across different age groups and their individualized impact on mortality prediction. Moreover, we highlight interactions between risk factors associated with mortality prediction, which leads to findings that linear models do not reveal. We demonstrate that compared with traditional linear models, tree-based models have unique strengths such as: (1) improving prediction power, (2) making no distribution assumptions, (3) capturing non-linear relationships and important thresholds, (4) identifying feature interactions, and (5) detecting different non-linear relationships between models. Given the popularity of complex ML models in prognostic research, combining these models with explainability methods has implications for further applications of ML in medical fields. To our knowledge, this is the first study that combines complex ML models and state-of-the-art feature attributions to explain mortality prediction, which enables us to achieve higher prediction accuracy and gain new insights into the effect of risk factors on mortality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is funded by National Science Foundation [DBI-1552309] and National Institutes of Health [R35 GM 128638].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This work does not need approval of the IRB/oversight body.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.